Dachaigh › Leukemia Myeloid ann an Ìre Chronach
Sgrùdaidhean clionaigeach Leukemia Myeloid ann an Ìre Chronach a’ fastadh anns na SA
Tha 11 sgrùdaidhean airson Leukemia Myeloid ann an Ìre Chronach a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Houston, TX5 sgrùdaidhean
- New York City, NY3 sgrùdaidhean
- Portland, OR3 sgrùdaidhean
- Seattle, WA3 sgrùdaidhean
- Birmingham, AL3 sgrùdaidhean
Le stàit
- Alabama3 sgrùdaidhean
- California5 sgrùdaidhean
- Georgia3 sgrùdaidhean
- New York5 sgrùdaidhean
- North Carolina3 sgrùdaidhean
- Oregon4 sgrùdaidhean
- Texas6 sgrùdaidhean
- Washington3 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT01746836Study of Olverembatinib (HQP1351) in Patients With CML-CP
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT06423911Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04838041Personalized NK Cell Therapy in CBT
A’ fastadhÌre 2
Aoisean 15 gu 80 · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT02727803A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 28 Iuch 2026 · NCT07020533A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 20 Iuch 2026 · NCT07091019Registry of Older Patients With Cancer
A’ fastadhSgrùdadh amharc
Aoisean 65 agus nas sine · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT01137825MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
A’ fastadh
Aoisean 0 gu 25 · Gach gnè · Air ùrachadh 13 Cèit 2026 · NCT05794880A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Gibl 2026 · NCT05304377Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Màrt 2026 · NCT06229860A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Faoi 2026 · NCT06163430Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.